Patient Navigation to Improve Early Access to Supportive Care for Patients with Advanced Cancer in Resource-Limited Settings: A Randomized Controlled Trial.

Sergio Contreras-Garduño, Paul E Goss, Alejandro Mohar, Eucario León-Rodriguez, Héctor de la Mora-Molina, Roberto de la Peña-Lopez, María T Bourlon, Viridiana Perez-Montessoro, María Luisa Moreno-García, Andrea Medina-Campos, Itoro Inoyo, Lindsay Krush, Enrique Soto-Perez-de-Celis, Juan Alberto Chávarri-Maldonado, Alexandra Bukowski, José Carlos Aguilar-Velazco, Natasha Alcocer-Castillejos, Sofía Sánchez-Román, Paulina Quiroz-Friedman, África Navarro-Lara, Alfredo Covarrubias-Gomez, Jacqueline Alcalde-Castro, Wendy Alicia Ramos-Lopez, Yanin Chavarri-Guerra

Journal: The oncologist 2021;26(2):157-164

PMID: 33210345

Abstract

BACKGROUND

The early integration of supportive care in oncology improves patient-centered outcomes. However, data are lacking regarding how to achieve this in resource-limited settings. We studied whether patient navigation increased access to multidisciplinary supportive care among Mexican patients with advanced cancer.

MATERIALS AND METHODS

This randomized controlled trial was conducted between August 2017 and April 2018 at a public hospital in Mexico City. Patients aged ≥18 years with metastatic tumors ≤6 weeks from diagnosis were randomized (1:1) to a patient navigation intervention or usual care. Patients randomized to patient navigation received personalized supportive care from a navigator and a multidisciplinary team. Patients randomized to usual care obtained supportive care referrals from treating oncologists. The primary outcome was the implementation of supportive care interventions at 12 weeks. Secondary outcomes included advance directive completion, supportive care needs, and quality of life.

RESULTS

One hundred thirty-four patients were randomized: 67 to patient navigation and 67 to usual care. Supportive care interventions were provided to 74% of patients in the patient navigation arm versus 24% in usual care (difference 0.50, 95% confidence interval [CI] 0.34-0.62; p < .0001). In the patient navigation arm, 48% of eligible patients completed advance directives, compared with 0% in usual care (p < .0001). At 12 weeks, patients randomized to patient navigation had less moderate/severe pain (10% vs. 33%; difference 0.23, 95% CI 0.07-0.38; p = .006), without differences in quality of life between arms.

CONCLUSION

Patient navigation improves access to early supportive care, advance care planning, and pain for patients with advanced cancer in resource-limited settings.

IMPLICATIONS FOR PRACTICE

The early implementation of supportive care in oncology is recommended by international guidelines, but this might be difficult to achieve in resource-limited settings. This randomized clinical trial including 134 Mexican patients with advanced cancer demonstrates that a multidisciplinary patient navigation intervention can improve the early access to supportive and palliative care interventions, increase advance care planning, and reduce symptoms compared with usual oncologist-guided care alone. These results demonstrate that patient navigation represents a potentially useful solution to achieve the adequate implementation of supportive and palliative care in resource-limited settings globally.

© 2020 AlphaMed Press.

Address: Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.; Department of Pain and Palliative Care Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.; Physical Therapy Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.; Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.; Global Cancer Institute, Boston, Massachusetts, USA.; Universidad Autónoma de Ciudad Juárez, Cd Juárez, Mexico.; Unidad de Investigación Biomédica, Instituto Nacional de Cancerología Universidad Nacional Autónoma de México, Tlalpan, Mexico City, Mexico.; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.